Phenol

Phenol Medicine

Overdose

Symptoms:

The symptoms of overdosage after submucosal injection of Oily Phenol are not known, but are likely to be similar to symptoms observed after excessive exposure to phenol in other preparations. Absorption of phenol after application of dilute phenol solutions to extensive wounds has resulted in abdominal pains, dizziness, methaemoglobinaemia, haemoglobinurea, cyanosis, cardiac arrhythmias, ECG abnormalities, and may result in respiratory failure, circulatory failure, coma and death.

Treatment: There is no specific antidote for actute phenol overdose. Treatment of overdose is symptomatic and supportive. If the product has been swallowed, empty the stomach by aspiration and lavage, taking care to avoid perforation, before carrying out the above procedure.

Shelf life

3 years (36 month) when packaged in glass ampoules

18 month when packaged in glass vials with rubber caps and aluminium crimps.

Contraindications

Oily Phenol Injection, BP is contraindicated in patients who are hypersensitive to phenol, nuts and in particular almond oil or any component of the product. It should not be used over large areas, since sufficient amounts may be absorbed to give rise to toxic symptoms. Oily Phenol Injection, BP is also contraindicated in neonates and children.

Incompatibilities

None stated

List of excipients

Almond oil BP

Pharmaceutical form

Injection.

Undesirable effects

General disorders and administration site conditions:

Pyrexia

Pain

Discomfort

Irritation

Ulcer

Tissue necrosis

Immune system disorders:

Hypersensitivity

Nervous system disorders:

Dizziness

Hepatobiliary disorders:

Hepatitis

Infections and infestations:

Abscess

Prostatic abscess

Necrotizing fasciitis

Retroperitoneal sepsis

Renal and urinary disorders:

Dysuria

Urinary incontinence

Reproductive system and breast disorders:

Impotence

Preclinical safety data

Not applicable

Therapeutic indications

Analgesic sclerosing agent in the treatment of internal haemorrhoids

Pharmacodynamic properties

The injection produces submucosal fibrosis, fixing the mucosa to the underlying muscle.

Pharmacokinetic properties

Not applicable

Date of revision of the text

17/06/2010

Name of the medicinal product

Oily Phenol Injection 5% w/v.

Marketing authorisation holder

Macarthys Laboratories Limited

T/A Martindale Pharmaceuticals

Martindale Pharmaceuticals

Bampton Road, Romford, RM3 8UG.

Special precautions for storage

Not applicable

Nature and contents of container

Clear glass ampoules containing 2 ml or 5 ml of product. 10 ampoules are packed into cartons. Glass vials containing 25 ml of product closed with rubber bungs sealed with aluminium caps.

Marketing authorisation number(s)

PL 01883/6153R

Qualitative and quantitative composition

Each ml of solution contains 50 mg Phenol BP.

Special warnings and precautions for use

For submucosal injection only. Not for intrathecal use. Care should also be taken to avoid accidental intravenous injection. The injection may cause severe pain if it is too close to the anal verge. Complications of therapy can include local ulceration and sterile abscess formation. These complications may be serious following a misplaced injection (eg prostatic abscess). Care in choosing the correct site of injection is mandatory.

Effects on ability to drive and use machines

Not applicable

Dosage (Posology) and method of administration

By submucosal injection

Adults and the elderly

2 - 3 ml injected at the base of the haemorrhoid. Several sites may be injected but the maximum total at any one time is 10 ml.

Children

The use of oily phenol injection BP is contraindicated in children and neonates.

Special precautions for disposal and other handling

None

Date of first authorisation/renewal of the authorisation

First authorised: 22nd June, 1989

Last renewal:18th October, 1994